CoChat

Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer

Open access
Snahnicanova, Zuzana, Kasubova, Ivana, Kalman, Michal, Grendar, Marian, Mikolajcik, Peter, Gabonova, Eva, Laca, Ludovit, Caprnda, Martin, Rodrigo, Luis, Ciccocioppo, Rachele, Kruzliak, Peter, Plank, Lukas, Lasabova, Zora · 2020 · Clinical and Experimental Medicine

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Abstract

One of the most common mechanisms of immune evasion in MSI colorectal cancers (CRCs) is loss of HLA class I expression due to mutations in B2M gene which can become a negative predictor for checkpoint blockade therapy. The aim of this study was the determination of prevalence of B2M somatic mutations in MSI CRC patients and relationship between B2M mutations and lymphocytes infiltration and other clinicopathological features as well as detection of methylation changes in B2M promoter region which can be another mechanism of immune escape. In our study, 37 MSI-H and 5 MSI-L patients were selected for screening of B2M mutational and methylation status. The characterization of patients was based on standard histopathological diagnosis and TNM classification; BRAF, KRAS mutations, tumor-infiltrating lymphocytes and peritumoral lymphoid reaction were also determined. MSI analysis was performed using fragment analysis. B2M mutations were identified by Sanger sequencing, and methylation of CpG islands in promoter region was detected by methylation-specific PCR. Heterozygous mutations in the B2M gene were detected in five MSI-H patients (13.5%), while the mutation c.45_48delTTCT was determined in four patients and mutation c.276delC was found in two patients. One of these five patients was compound heterozygote harboring both mutations. Methylation of the promoter region of the B2M gene was observed in one patient with MSI-H colorectal cancer. Detection of genetic and epigenetic changes in B2M gene could be important in personalized therapy for CRC patients as these changes may be one of the mechanisms of secondary resistance of MSI positive tumors to immunotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10238-019-00601-7

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Cited by

See all 35

Metadata

Authors
Snahnicanova, Z., Kasubova, I., Kalman, M., Grendar, M., Mikolajcik, P., Gabonova, E., Laca, L., Caprnda, M., Rodrigo, L., Ciccocioppo, R., Kruzliak, P., Plank, L., & Lasabova, Z.
Affiliations
  • Martin University Hospital (SK)
  • Comenius University Bratislava (SK)
  • University of Verona (IT)
Venue
Clinical and Experimental Medicine
Published
2019-12-18
Volume
20
Issue
1
Pages
87-95
ISSN
  • 1591-8890 (ISSN-L)
  • 1591-9528
OpenAlex
W2995284100
Cited by
29
References
55
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 3
FWCI
2.39
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical and Experimental Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte) (submittedVersion, cc-by-nc-nd)
Funders
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR (APVV-16-0066)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
beta2-microglobulin, microsatellite instability, colorectal cancer, immune evasion, HLA class I loss, promoter methylation, tumor-infiltrating lymphocytes, immunotherapy resistance, checkpoint blockade, compound heterozygosity
MeSH terms
Adult, Aged, Aged, 80 and over, beta 2-Microglobulin, Female, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Promoter Regions, Genetic, Colorectal Neoplasms, Down-Regulation, Gene Expression Regulation, Neoplastic, CpG Islands, DNA Methylation, Epigenesis, Genetic, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer. https://app.cochat.ai/papers/10.1007/s10238-019-00601-7
The paper
Snahnicanova, Z., Kasubova, I., Kalman, M., Grendar, M., Mikolajcik, P., Gabonova, E., Laca, L., Caprnda, M., Rodrigo, L., Ciccocioppo, R., Kruzliak, P., Plank, L., & Lasabova, Z. (2020). Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-019-00601-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.